ProPhase Labs
在场
ProPhase Labs 是一家在股票代码 PRPH (US) 下上市的公司。
高管
查看带有其 9 名主要高管的组织结构图
ProPhase Labs 搜索最多的简介
- Ted Karkus, Chief Executive Officer and Chairman of the Board
- Louis Gleckel, Director
- Eleanor Mcbrier, Director
创建提醒
跟踪 ProPhase Labs 的高管变动
生物技术
ProPhase Labs 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
ProPhase Labs 的最新新闻稿
- ProPhase Labs Announces Closing of Public Offering of Common Stock
- ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024
- Press Releases
- ProPhase Labs Announces Pricing of Public Offering of Common Stock
- ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024
- ProPhase Labs Announces Proposed Public Offering of Common Stock
- ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry
- ProPhase Labs to Present at the 2024 ThinkEquity Conference
- ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025
- View more press releases Close
关于 ProPhase Labs 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Ted Karkus 
